Edit CMD

An interesting study of the role of deltiasm in patients who have what we call a noka or angina with no obstructive coronary disease. VupaNorsen is an angPTL3 inhibitor and has been shown to reduce levels of LDL cholesterol, also levels of triglycerides. Unfortunately there was a significant increase in adverse treatment effects particularly injection site reactions leading to a number of patients discontinuing or having difficulty with therapy. So as a result of that this medication is no longer moving forward as a potential therapy for reducing non-HDL cholesterol.